Bicara Therapeutics Inc. ... (BCAX)

NASDAQ: BCAX · Real-Time Price · USD

14.69

-0.02 (-0.14%)

At close: May 02, 2025, 3:59 PM

14.50

-1.26%

After-hours: May 02, 2025, 04:05 PM EDT

Bicara Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-68M	-51.98M	-37.84M
Depreciation & Amortization	56K	19K	10K
Stock-Based Compensation	7.4M	1.9M	810K
Other Working Capital	-14.13M	-9.62M	4.95M
Other Non-Cash Items	-77K	14.06M	n/a
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	-14.13M	-9.62M	4.95M
Operating Cash Flow	-74.75M	-45.63M	-32.08M
Capital Expenditures	-71K	-586K	-192K
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a
Other Investing Acitivies	62K	n/a	n/a
Investing Cash Flow	-9K	-586K	-192K
Debt Repayment	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	1.6M	n/a	n/a
Financial Cash Flow	334.03M	272.5M	31.7M
Net Cash Flow	259.27M	226.28M	-573K
Free Cash Flow	-74.82M	-46.21M	-32.27M